Angiogenesis Foundation Inc.
Fiscal year ending 2024. Filed on February 15, 2025.
One Broadway 14th Floor
Cambridge, Massachusetts 02142
Angiogenesis Foundation Inc. (EIN: 04-3266422) has filed an IRS Form 990 since at least fiscal year 2016. In its fiscal year 2024 IRS Form 990 filing, Angiogenesis Foundation Inc., a 501(c)(3) charitable organization, reported compensation for 3 out of 8 total employees. Among the employees shown here, the average compensation is $251,268. The highest compensated employee at Angiogenesis Foundation Inc. is William W Li, M.D. with fiscal year 2024 compensation of $326,616.
Revenue, expenses, and employee compensation
Revenue
Expenses
Employee compensation
Reported Compensated Employees
Mission Statement
TO IMPROVE GLOBAL HEALTH BY ADVANCING ANGIOGENESIS-BASED MEDICINE, DIET, AND LIFESTYLE. GOALS: 1) ADVANCE MODERN MEDICINE BY CHAMPIONING A NEW APPROACH TO CONQUERING DISEASE. 2) HELP PEOPLE LEAD LONGER HEALTHIER LIVES. 3) TRANSFORM THE WAY SOCIETY VIEWS HEALTH AND DISEASE THROUGH PUBLIC AWARENESS AND ADVOCACY, AND RESEARCH ON EVIDENCE-BASED DISEASE PREVENTION AND INTERVENTION.
Revisions to this organization profile
Get an email when new compensation information is released for Angiogenesis Foundation Inc.
Be the first to know when new IRS Form 990 data is published for this organization.